Newsroom

Categories: Biomanufacturing, Corporate, Finance & Investor

Champalimaud Foundation adopts Lonza’s MODA-ES® Platform to streamline cell therapy manufacturing

August 13, 2024

Categories: Biomanufacturing, Clinical Research & Trials

Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage

June 11, 2024

Categories: Biomanufacturing, Computing & Technology, Corporate, Finance & Investor

The only LIMS platform fully developed on FAIR data principles launches at Bio-IT World 2023

May 25, 2023

Categories: Biomanufacturing, Pharma, Corporate, Finance & Investor

New Lonza Webinar — “Taking the Leap into an MES from a CEO’s Perspective”

April 20, 2023

Categories: Biomanufacturing, Biotechnology

Fraunhofer IZI selects Lonza’s MODA-ES® Solution to digitalize manufacturing operations

December 6, 2022

Categories: Omics & Genetics, Biomanufacturing

“Genome Editing of Immune Cells” - New Lonza virtual event

September 6, 2022

Categories: Biomanufacturing, Biotechnology

Creoptix launches new WAVEcontrol software to deliver automated, flexible and intuitive label-free interaction analysis for biologics drug-discovery

August 4, 2022

Categories: Biomanufacturing, Corporate, Finance & Investor

New Lonza Panel Discussion — “The Reality of MES Implementation”

May 24, 2022

Categories: Biomanufacturing, Drug Discovery & Development, Corporate, Finance & Investor

CYTENA and ExcellGene to develop automated workflows for biotherapeutics cell line development

May 3, 2022